Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AIMDWNASDAQ:BBLGWOTCMKTS:CLLKFOTCMKTS:IOBCF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAIMDWAinos$0.10-14.0%$0.12$0.03▼$0.37N/AN/A18,487 shs566 shsBBLGWBone Biologics$13.50$16.00$3.00▼$95.04N/AN/A2,005 shs19 shsCLLKFBICO Group AB (publ)C$3.88C$3.69C$2.59▼C$5.60N/AN/A1,644 shs40 shsIOBCFIon Beam Applications$14.23$12.24$10.15▼$15.75N/AN/A737 shs5 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAIMDWAinos0.00%-7.11%-36.20%-48.28%+42.24%BBLGWBone Biologics0.00%0.00%0.00%-33.17%-67.56%CLLKFBICO Group AB (publ)0.00%+1.33%+3.47%+6.01%-9.56%IOBCFIon Beam Applications0.00%+3.10%+11.59%+1.55%-4.51%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAIMDWAinosN/AN/AN/AN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/AN/AN/AIOBCFIon Beam Applications0.0087 of 5 stars0.01.00.00.00.00.00.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAIMDWAinos 0.00N/AN/AN/ABBLGWBone Biologics 0.00N/AN/AN/ACLLKFBICO Group AB (publ) 0.00N/AN/AN/AIOBCFIon Beam Applications 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAIMDWAinos$106.21KN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AN/AIOBCFIon Beam ApplicationsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAIMDWAinosN/AN/A0.00∞N/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/A0.00∞N/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/A0.00∞N/AN/AN/AN/AN/AIOBCFIon Beam ApplicationsN/A$0.08167.85∞N/AN/AN/AN/A8/28/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAIMDWAinosN/AN/AN/AN/AN/ABBLGWBone BiologicsN/AN/AN/AN/AN/ACLLKFBICO Group AB (publ)N/AN/AN/AN/AN/AIOBCFIon Beam ApplicationsN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/AIOBCFIon Beam Applications14.86%Insider OwnershipCompanyInsider OwnershipAIMDWAinosN/ABBLGWBone BiologicsN/ACLLKFBICO Group AB (publ)N/AIOBCFIon Beam ApplicationsN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAIMDWAinos40N/AN/ANot OptionableBBLGWBone Biologics2N/AN/ANot OptionableCLLKFBICO Group AB (publ)880N/AN/ANot OptionableIOBCFIon Beam Applications2,000N/AN/ANot OptionableIOBCF, AIMDW, CLLKF, and BBLGW HeadlinesRecent News About These CompaniesIon Beam Applications (OTCMKTS:IOBCF) Trading Up 3.1% - Here's What HappenedJune 11, 2025 | americanbankingnews.comIon Beam Applications SA (IOBCF) (FY 2024) Earnings Call Highlights: Record Revenue and ...March 21, 2025 | gurufocus.comFull Year 2024 Ion Beam Applications SA Earnings Call TranscriptMarch 21, 2025 | gurufocus.comIon Beam Applications SA (IOBCF) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comIBA Achieves Record Revenue and Profitability in 2024March 20, 2025 | tipranks.comApollo Hospitals to procure proton therapy solution from IBAMarch 5, 2025 | msn.comApollo Hospitals, IBA to introduce Proteus One-PBT in IndiaMarch 4, 2025 | dailyexcelsior.comApollo Hospitals partners with IBA to introduce Proteus One proton therapy in IndiaMarch 4, 2025 | expresshealthcare.inIBA and Apollo Hospitals sign a term sheet for one Proteus®ONE system plus a second one in option to be installed in IndiaMarch 4, 2025 | finance.yahoo.comApollo Hospitals Joins Forces with Ion Beam Applications for Advanced Cancer TreatmentMarch 4, 2025 | devdiscourse.comIBA Expands Proton Therapy Partnership with Apollo Hospitals in IndiaMarch 4, 2025 | tipranks.comIBA Notice of Full Year 2024 Results and Conference CallFebruary 27, 2025 | finance.yahoo.comIBA and Jabil Partner for Advanced Sterilization Solution in MississippiFebruary 25, 2025 | tipranks.comNotice of Capital Markets Day - Save the DateFebruary 18, 2025 | finance.yahoo.comIBA – Transparency Notification IBA SAFebruary 11, 2025 | finance.yahoo.comFramatome and IBA to partner on development of Astatine-211February 11, 2025 | neimagazine.comFramatome and IBA to partner to develop an Astatine-211 Cyclotron Network in Europe and the USAFebruary 7, 2025 | manilatimes.netIBA Secures Proton Therapy System Contract with AIG Hospitals in IndiaFebruary 6, 2025 | tipranks.comIBA and Wallonie Entreprendre International secure 30% stake in mi2-factory to support improved efficiency of silicon carbide-powered devicesJanuary 21, 2025 | finance.yahoo.comIBA and Wallonie Entreprendre Invest in mi2-factory to Boost SiC Chip EfficiencyJanuary 21, 2025 | tipranks.comMedia Sentiment Over TimeIOBCF, AIMDW, CLLKF, and BBLGW Company DescriptionsAinos NASDAQ:AIMDW$0.10 -0.02 (-14.04%) As of 06/13/2025 12:22 PM EasternAinos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women's health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.Bone Biologics NASDAQ:BBLGW$13.50 0.00 (0.00%) As of 06/13/2025Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with spinal degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.BICO Group AB (publ) OTCMKTS:CLLKFC$3.88 0.00 (0.00%) As of 06/13/2025BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end products and services in precision dispensing, advanced sample preparation, multiplex analysis and assay miniaturization, diagnostic and medical device manufacturing for life science and diagnostic industries. It primarily serves medical, pharmaceutical, and cosmetic industries. The company offers its products through sales organizations, as well as through an extensive distributor network. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was incorporated in 2016 and is headquartered in Gothenburg, Sweden.Ion Beam Applications OTCMKTS:IOBCF$14.23 0.00 (0.00%) As of 06/13/2025Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Palantir Defies Bears, Leads S&P 500 in 2025 AST SpaceMobile’s Star Is Rising: Get in While It’s Still Cheap! Could Meta and Eli Lilly Trigger the Next Stock Split Boom? Iran Conflict Fuels Fertilizer Stocks’ Bullish Setup Is D-Wave's Latest $400M Sales Agreement a Dilution Deal-Breaker? Why Analysts Are Bullish on Celsius Stock After 30% Drop 3 Stocks With Rising Dividends Investors Shouldn’t Ignore SoundHound’s AI Growth Story Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
